Who owns COMPUGEN LTD (CGEN)? Elite investor 13F holders
2 tracked elite investors reported holding COMPUGEN LTD as of 2026-06-30, including Renaissance Technologies LLC, Matrix Asset Advisors. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
2 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe. The company's pipeline consists of COM701, an immuno-oncology pipeline program with an anti-PVRIG antibody; COM902, a therapeutic anti-TIGIT antibody, are in Phase 1 clinical…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | COMPUGEN LTD | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 4017850.00 USD | 1877500.000000 | Shares | add | Original filing |
| Matrix Asset Advisors | COMPUGEN LTD | SHARE | 2026-06-30 | 2026-07-15 00:00:00 | 200803.00 USD | 93833.000000 | Shares | hold | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.